NCT02076230 2016-06-10A Phase 1 TH-302 Mass Balance TrialMerck KGaA, Darmstadt, GermanyPhase 1 Completed10 enrolled
NCT02020226 2016-06-02A Cardiac Safety Study of TH-302 in Patients With Advanced Solid TumorsThreshold PharmaceuticalsPhase 1 Unknown40 enrolled